Research Article

Clinical Characteristics of Patients with Hepatocellular Carcinoma: A Single-Center 3-Year Experience from Somalia

Table 1

Comparison of hepatocellular carcinoma (HCC) patients by portal vein thrombosis (PVT+/-) (), Jan 2017–Dec 2019, Somalia.

PVT (-)
()
PVT (+)
()

Gender (%)
Male163 (82.7)34 (17.3)0.210
Female63 (90)7 (10)
Age (median)(years)40 (22-76)55 (18-100)0.009
AFP2000 (201-2000)2000 (203-2000)0.014
AST (U/L)97 (0-4483)216 (0-16335)0.001
ALT (U/L)39 (0-1269)77 (0-3456)0.001
Creatinine (mg/dl)0.6 (0-5.1)0.7 (0-8.4)0.206
Direct_Bilirubin (μmol/L)0.2 (0-93)1.2 (0-28.43)0.001
Protrombin time (seconds)0 (0-61.9)0 (0-59.5)0.230
Total_Bilirubin (μmol/L)0.55 (0-30)3.3 (0-34.87)<0.001
Albumin (g/L)2.85 (0-5.1)2.7 (0-4.4)0.836
GGT (U/L)0 (0-987)36 (0-876)0.202
ALP (U/L)0 (0-1325)178 (0-1750)0.023
Hb (g/dl)7 (0-15)8 (0-13)0.637
Platelet (×109/L)70 (0-996)72.5 (0-876)0.657
WBC×1039 (0-987)13 (0-86)0.270
CRP54 (0-987)65 (0-865)0.355
Tumor size (cm)4 (0-27)8 (0-30)0.010
Child-Pugh
A175 (89.3)21 (10.7)0.001
B33 (71.7)13 (28.3)
C17 (70.8)7 (29.2)
Cirrhosis (-) (%)163 (86.7)25 (13.3)0.195
Cirrhosis (+) (%)62 (79.5)16 (20.5)
Number of nodules
Unifocal34 (79.1)9 (20.9)0.703
Multifocal33 (73.3)12 (26.7)
Tumor distribution
Unilobular199 (85.4)34 (14.6)0.515
Bilobular27 (79.4)7 (20.6)
Maximal tumor size (cm)
  <5 cm111 (89.5)13 (10.5)0.087
5-1032 (84.2)6 (15.8)
  >1083 (79)22 (21)

Abbreviations: ALT: alanine aminotransferase; AST: aspartate aminotransferase; PT: prothrombin time; GGT: gamma glutamyl transpeptidase; INR: international normalized ratio; PT: prothrombin time; AFP: alpha fetoprotein; WBCs: white blood cells; CRP: C-reactive protein; normal values: ALT (5–45 U/L), AST (5–40 U/L), alkaline phosphatase (38–155 U/L), albumin (2.5–6.0 g/dL), total serum bilirubin (0.1–1.3 mg/dL), and serum direct bilirubin (0.0–8.4 mg/dL).